Nicotinamide N-methytransferase (NNMT) protein monoclonal antibody, hybridoma cell strain and application

A hybridoma cell line, monoclonal antibody technology, applied in the direction of anti-enzyme immunoglobulin, biochemical equipment and methods, instruments, etc., can solve the problems affecting the effect of radiation and radiotherapy, and achieve the effect of high antibody titer

Inactive Publication Date: 2012-08-01
ZHEJIANG UNIV
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These studies suggest that NNMT is closely related to tumorigenesis. It is speculated that NNMT may participate in various biological funct

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nicotinamide N-methytransferase (NNMT) protein monoclonal antibody, hybridoma cell strain and application
  • Nicotinamide N-methytransferase (NNMT) protein monoclonal antibody, hybridoma cell strain and application
  • Nicotinamide N-methytransferase (NNMT) protein monoclonal antibody, hybridoma cell strain and application

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0030] Example 1: Acquisition of Hybridoma Cell Lines, Screening and Preparation of Monoclonal Antibodies

[0031] 1. Preparation of monoclonal antibodies

[0032] 1.1. Preparation of immunogens

[0033] The immunogen is GST-NNMT fusion protein and NNMT protein. NNMT protein was prepared by genetic engineering technology: pGEX-4T-2 / NNMT plasmid was constructed and transformed into Escherichia coli BL-21-STAR (DE3) to express GST-NNMT fusion protein . Then, after the fusion protein was purified, the fusion protein was fully digested by adding thrombin, and the NNMT protein (geneBank accession number: ACA06031.1) was obtained after purification again.

[0034] 1.2. Animal immunity:

[0035] The immunization procedure was as follows: 6-8 week-old BALB / C female mice were taken for the initial immunization, NNMT protein and Freund's complete adjuvant were mixed in equal volumes, and then injected subcutaneously on the back of the mice at multiple points, with a dose of 120 μg pe...

Example Embodiment

[0082] Example 2: Application of monoclonal antibodies to immunohistochemical detection of clinical specimens (two-step indirect method)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a hybridoma cell strain of NNMT protein monoclonal antibody, a monoclonal antibody secreted by the cell strain and application. The monoclonal antibody of the invention has a high antibody titer, affinity and high purity after purification to NNMT proteins, thus indicating that the monoclonal antibody can be applied in the scientific research field of NNMT proteins as well as in clinic detection for immunohistochemistry of pathological sections of different pathologic tissues to detect expression of NNMT proteins in the tissues. Therefore, the monoclonal antibody provided in the invention contributes to diagnosis, treatment and prognosis of NNMT associated tumors.

Description

(1) Technical field [0001] The present invention relates to nicotinamide-N-methylase (NNMT, EC2.1.1.1) protein monoclonal antibody hybridoma cell line, monoclonal antibody, and monoclonal antibody in preparation and detection of nicotinamide-N-methylase Application of protein kits. (2) Background technology [0002] Malignant tumors seriously endanger human health. According to the latest data from the World Health Organization, by 2020, there will be 15 million new cancer patients every year. Not only that, the number of cancer deaths is also rising rapidly around the world. In 2007, a total of 7.6 million people died worldwide. For cancer, this number may increase to 13.2 million in 2030. [0003] Early diagnosis of tumors is the key to cancer prevention and treatment. The risk of death and recurrence of tumors is closely related to the stage at the time of initial diagnosis, and the sensitivity of chemotherapy and radiotherapy depends to a certain extent on the enzymes o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/20C07K16/40G01N33/577C12R1/91
Inventor 张钧谢鑫友杨肃文王燕忠
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap